Gilead Sciences

GILD

32 Followers

$105.7

-0.77%

-$0.82

Follow

April 23

Upcoming Earnings

$132B

Market Cap.

274.77

P/E

Overview Metrics Financials

Breakdown	12/31/2024 USD	12/31/2023 USD	12/31/2022 USD	12/31/2021 USD
Total revenue	28,754,000 +6.04%	27,116,000 -0.60%	27,281,000 -0.09%	27,305,000 -
Cost of revenue	6,251,000 -3.80%	6,498,000 +14.87%	5,657,000 -14.30%	6,601,000 -
Gross profit	22,503,000 +9.14%	20,618,000 -4.65%	21,624,000 +4.44%	20,704,000 -
Operating expense	20,841,000 +52.47%	13,669,000 +28.35%	10,650,000 +0.39%	10,609,000 -
Operating income	1,662,000 -78.15%	7,605,000 +3.75%	7,330,000 -1.03%	7,406,000 -
Pretax Income	690,000 -89.94%	6,859,000 +17.97%	5,814,000 -29.77%	8,278,000 -
Tax Provision	211,000 -83.08%	1,247,000 -0.08%	1,248,000 -39.91%	2,077,000 -
Net income	480,000 -91.53%	5,665,000 +23.37%	4,592,000 -26.23%	6,225,000 -
EPS	0.38 -91.63%	4.54 +24.04%	3.66 -26.21%	4.96 -
Diluted EPS	0.38 -91.56%	4.5 +23.63%	3.64 -26.17%	4.93 -
Average Shares	1,247,000 -0.08%	1,248,000 -0.56%	1,255,000 -0.08%	1,256,000 -
Diluted Average Shares	1,255,000 -0.24%	1,258,000 -0.32%	1,262,000 0.00%	1,262,000 -
EBIT	1,667,000 -78.64%	7,803,000 +15.62%	6,749,000 -27.27%	9,279,000 -
EBITDA	1,662,000 -84.17%	10,496,000 +18.57%	8,852,000 -21.86%	11,329,000 -

We use cookies to improve your experience on our site.